Melike Özçelik

512 total citations
40 papers, 232 citations indexed

About

Melike Özçelik is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Melike Özçelik has authored 40 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Melike Özçelik's work include HER2/EGFR in Cancer Research (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Melike Özçelik is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Melike Özçelik collaborates with scholars based in Türkiye, Cambodia and Antigua and Barbuda. Melike Özçelik's co-authors include Özlem Erçelep, Mahmut Gümüş, Mehmet Aliustaoğlu, Mehmet Çelik, Hatice Odabaş, Mesut Şeker, Dilek Yavuzer, Umut Kefeli, Hülya Ilıksu Gözü and Ahmet Bılıcı and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Melike Özçelik

33 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melike Özçelik Türkiye 10 95 78 56 45 30 40 232
Asad Haider United States 6 65 0.7× 45 0.6× 75 1.3× 33 0.7× 49 1.6× 13 287
Changyoung Yoo South Korea 10 90 0.9× 45 0.6× 140 2.5× 73 1.6× 29 1.0× 32 304
Byeong‐Joo Noh South Korea 11 101 1.1× 106 1.4× 86 1.5× 90 2.0× 28 0.9× 30 327
Cristiano Lanza Italy 10 126 1.3× 87 1.1× 58 1.0× 85 1.9× 32 1.1× 18 282
C S Kang South Korea 7 60 0.6× 57 0.7× 58 1.0× 34 0.8× 51 1.7× 7 191
Mitsuko Iguchi Japan 9 31 0.3× 54 0.7× 36 0.6× 57 1.3× 36 1.2× 35 179
David Papadimos Australia 8 87 0.9× 70 0.9× 62 1.1× 40 0.9× 30 1.0× 11 205
Aiko Kurisaki‐Arakawa Japan 10 79 0.8× 182 2.3× 66 1.2× 32 0.7× 49 1.6× 17 331
Hazel Lote United Kingdom 8 116 1.2× 78 1.0× 37 0.7× 39 0.9× 18 0.6× 17 198
Haipeng Guo China 9 63 0.7× 42 0.5× 78 1.4× 90 2.0× 34 1.1× 23 253

Countries citing papers authored by Melike Özçelik

Since Specialization
Citations

This map shows the geographic impact of Melike Özçelik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melike Özçelik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melike Özçelik more than expected).

Fields of papers citing papers by Melike Özçelik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melike Özçelik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melike Özçelik. The network helps show where Melike Özçelik may publish in the future.

Co-authorship network of co-authors of Melike Özçelik

This figure shows the co-authorship network connecting the top 25 collaborators of Melike Özçelik. A scholar is included among the top collaborators of Melike Özçelik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melike Özçelik. Melike Özçelik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Özçelik, Melike, et al.. (2024). KRAS G12C mutation in NSCLC in a small genetic center: insights into sotorasib therapy response potential. Scientific Reports. 14(1). 26581–26581.
3.
4.
Odabaş, Hatice, et al.. (2023). Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?. Medicina. 59(3). 557–557. 10 indexed citations
5.
6.
7.
Özçelik, Melike, et al.. (2021). Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. Journal of College of Physicians And Surgeons Pakistan. 31(11). 1308–1313. 3 indexed citations
8.
Çelik, Mehmet, et al.. (2021). Role of testosterone to estradiol ratio in predicting the efficacy of recombinant human chorionic gonadotropin and testosterone treatment in male hypogonadism. Archives of Endocrinology and Metabolism. 65(5). 617–624. 2 indexed citations
9.
Çelik, Mehmet, et al.. (2021). Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient?. Journal of Oncology Pharmacy Practice. 28(2). 462–465. 1 indexed citations
10.
Erçelep, Özlem, et al.. (2020). Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer. Journal of Turkish Society of Obstetric and Gynecology. 17(2). 123–127. 1 indexed citations
11.
Ağaoğlu, Nihat Buğra, Gizem Alkurt, Jale Yıldız, et al.. (2020). Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls. International Journal of Cancer. 148(2). 285–295. 30 indexed citations
12.
Bircan, Rıfat, Aylin Gül, Büşra Aydın, et al.. (2019). BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure. Endokrynologia Polska. 70(5). 401–408. 6 indexed citations
13.
Erdem, Gökmen Umut, Mutlu Doğan, Abdullah Sakin, et al.. (2018). Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncology Research and Treatment. 41(4). 220–225. 2 indexed citations
14.
Erçelep, Özlem, Melike Özçelik, & Mahmut Gümüş. (2018). Association of lymphadenectomy and survival in epithelial ovarian cancer. Current Problems in Cancer. 43(2). 151–159. 14 indexed citations
15.
Erçelep, Özlem, Nuriye Özdemir, Nedim Turan, et al.. (2018). Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas. Current Problems in Cancer. 43(1). 27–32. 7 indexed citations
16.
Erçelep, Özlem, İbrahim Vedat Bayoğlu, Halil Kavgacı, et al.. (2016). Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology. Tumor Biology. 37(9). 12033–12038. 8 indexed citations
17.
Şendur, Mehmet Alı Nahıt, Umut Kefeli, Bala Başak Öven Ustaalıoğlu, et al.. (2016). Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma. Clinical Colorectal Cancer. 16(1). 78–83. 17 indexed citations
18.
Ünal, Olçun Ümit, İlhan Öztop, Serkan Menekşe, et al.. (2015). Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO). Asian Pacific Journal of Cancer Prevention. 16(11). 4777–4780.
19.
Bılıcı, Ahmet, Dilek Yavuzer, Umut Kefeli, et al.. (2015). Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy. Clinical & Translational Oncology. 17(8). 604–611. 19 indexed citations
20.
Özçelik, Melike, Mesut Şeker, Özlem Erçelep, et al.. (2015). Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology. Tumor Biology. 37(4). 5231–5237. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asad Haider Breakdown of academic impact, for papers by Changyoung Yoo Breakdown of academic impact, for papers by Byeong‐Joo Noh Breakdown of academic impact, for papers by Cristiano Lanza Breakdown of academic impact, for papers by C S Kang Breakdown of academic impact, for papers by Mitsuko Iguchi Breakdown of academic impact, for papers by David Papadimos Breakdown of academic impact, for papers by Aiko Kurisaki‐Arakawa Breakdown of academic impact, for papers by Hazel Lote Breakdown of academic impact, for papers by Haipeng Guo
Rankless by CCL
2026